Skip to main content
Journal of Dental Research logoLink to Journal of Dental Research
. 2013 Jun;92(6):512–517. doi: 10.1177/0022034513487211

Tooth-surface-specific Effects of Xylitol

Randomized Trial Results

AV Ritter 1,*, JD Bader 1, MC Leo 2, JS Preisser 1, DA Shugars 1, WM Vollmer 2, BT Amaechi 3, JC Holland 1
PMCID: PMC3654758  PMID: 23589387

Abstract

The Xylitol for Adult Caries Trial was a three-year, double-blind, multi-center, randomized clinical trial that evaluated the effectiveness of xylitol vs. placebo lozenges in the prevention of dental caries in caries-active adults. The purpose of this secondary analysis was to investigate whether xylitol lozenges had a differential effect on cumulative caries increments on different tooth surfaces. Participants (ages 21-80 yrs) with at least one follow-up visit (n = 620) were examined at baseline, 12, 24, and 33 months. Negative binomial and zero-inflated negative binomial regression models were used to estimate incidence rate ratios (IRR) for xylitol’s differential effect on cumulative caries increments on root and coronal surfaces and, among coronal surfaces, on smooth (buccal and lingual), occlusal, and proximal surfaces. Participants in the xylitol arm developed 40% fewer root caries lesions (0.23 D2FS/year) than those in the placebo arm (0.38 D2FS/year; IRR = 0.60; 95% CI [0.44, 0.81]; p < .001). There was no statistically significant difference between xylitol and control participants in the incidence of smooth-surface caries (p = .100), occlusal-surface caries (p = .408), or proximal-surface caries (p = .159). Among these caries-active adults, xylitol appears to have a caries-preventive effect on root surfaces (ClinicalTrials.gov NCT00393055).

Keywords: dental caries prevention, clinical trials, root caries, caries data analysis, sugar substitutes

Introduction

Dental caries results from an imbalance of demineralization and remineralization processes at the tooth-biofilm interface over time (Featherstone, 2004). These processes are modulated by modifying factors such as biofilm composition and pH, Ca and PO4 saturation in and buffer capacity of saliva, use (frequency and type) of fluoride and other caries-preventive agents, oral hygiene, diet, and tooth anatomy (Dawes, 2003; Khoo et al., 2005; Featherstone, 2008). Relative to the latter, conditions for demineralization-remineralization dynamics can be affected by specific ecological factors that characterize different tooth surfaces. For example, occlusal surfaces in posterior teeth have a different susceptibility to biofilm attachment (and possibly different biofilm composition and virulence) than do buccal surfaces in anterior teeth (Huang et al., 2011; Seneviratne et al., 2011). Smooth (buccal and lingual) coronal and root surfaces are more readily exposed to saliva’s remineralizing potential than are proximal surfaces and occlusal fissures. Additionally, because the critical pH for demineralization is higher for dentin than it is for enamel (Fejerskov and Kidd, 2008), root surfaces are considered to be at a higher caries risk than coronal surfaces (McIntyre et al., 2000). Therefore, when one is studying the effectiveness of interventions on caries prevention, it is important to examine their effects on these different tooth surfaces as a whole as well as separately (McDonald and Sheiham, 1992).

The Xylitol for Adult Caries Trial (X-ACT) was a three-year, placebo- controlled, double-blind, multi-center, randomized clinical trial that evaluated the effectiveness of xylitol lozenges in the prevention of dental caries in caries-active adults (Bader et al., 2010). The principal results of the X-ACT trial showed that daily use of 3 to 5 grams of xylitol did not result in a statistically significant reduction in overall caries increment when compared with use of a placebo (Bader et al., 2013). However, for the reasons discussed above, it is conceivable that xylitol may have different caries-preventive effects on various tooth surfaces.

The purpose of this study was to compare the caries-preventive effects of xylitol (1) on root and coronal surfaces and (2) among coronal surfaces, on smooth (buccal and lingual), occlusal, and proximal surfaces.

Materials & Methods

Study Design

The X-ACT study design has been described in detail elsewhere (Bader et al., 2010) and is summarized here. In total, 681 participants were randomized at 3 study clinical sites: The University of Alabama at Birmingham (UAB), The University of North Carolina at Chapel Hill (UNC), and The University of Texas Health Sciences Center at San Antonio (UTHSCSA). The Kaiser Permanente Center for Health Research (Portland, OR) served as the Data Coordinating Center. Institutional Review Boards at each clinical site approved the study, and all participants provided informed consent.

Recruitment, Inclusion and Exclusion Criteria

We recruited participants from dental school clinics, community dental clinics, and the general community. To be eligible, participants had to be aged 21 to 80 yrs, have at least 12 teeth with exposed dental surfaces, and have one or more coronal or root caries lesions either at the time of the baseline examination or documented within the preceding 12 mos. Exclusion criteria included the presence of more than 10 teeth with caries lesions, history of head and neck radiation, history of receiving long-term antibiotic therapy, and allergy to xylitol or other mint components. Following a 4-week run-in period (with placebo lozenges), eligible participants were randomized to receive xylitol or placebo lozenges. For the secondary analysis reported here, only participants with at least one follow-up visit and complete data on all covariates (n = 620, 91% of the 681 randomized participants) were included. This strategy avoided the inclusion of participants with questionable adherence data from one study site, as reported in the main outcomes paper (Bader et al., 2013). Data for all randomized participants are available at http://www.xactstudy.org.

Study Procedures

Participants received a caries examination at baseline and were scheduled to return yearly for three follow-up caries examinations. Before the 24-month visits began, the final examination schedule was shifted to 33 mos to adjust for slower-than-expected enrollment.

Study Treatments

The intervention consisted of 5 lozenges spaced across the day and dissolved in the mouth. The active lozenge contained 1.0 g of xylitol as a sweetening agent (other ingredients: polydextrose, magnesium stearate, and natural flavors). The placebo lozenge was identical to the active lozenge but was sweetened with sucralose. Both lozenges were supplied by Fennobon Oy (Karkkila, Finland).

Oral Examination

Caries examinations were completed at baseline, 12, 24, and 33 mos. To the extent possible, the follow-up examinations were performed by the same examiner who conducted the baseline examination. Examiners were trained and certified at the outset of recruitment and roughly annually thereafter (Banting et al., 2011). They also completed second examinations of approximately 5% of participants annually to determine intra-examiner reliability. Examiners used a dental mirror and a Community Periodontal Index of Treatment Needs (CPITN) dental probe. Magnifying loupes were used at the discretion of the examiner, but consistently throughout the trial. Radiographs were not used. With the help of a trained study recorder, examiners recorded coronal and root surfaces as either missing, sound, carious, restored (filled or crowned), or sealed, as well as surfaces that were unable to be scored. Root surfaces were anatomically defined as those surfaces apical to the cemento-enamel junction (CEJ).

Tooth surfaces were dried for 5 sec with an air/water syringe. Examiners used a modification of the International Caries Detection and Assessment System (ICDAS II) (Ismail et al., 2007) with 4 disease levels possible for each coronal surface [sound (S), non-cavitated enamel lesion (D1), cavitated lesion penetrating the enamel (D2), and cavitated lesion penetrating the dentin, or “shadowing” (D3)] and 3 disease levels possible for each root surface [sound (S), non-cavitated root lesion (D1), or cavitated root lesion (D2)]. Restored surfaces were noted as filled (F) or crowned (C), and pit-and-fissure sealants (P) were noted as sound. In addition, D3 lesions were grouped with D2 lesions (and are hereafter described as D2FS), and lesions adjacent to coronal or root restorations, crowns, and pit-and-fissure sealants were noted as such.

The mean intra-examiner reliability values (unweighted kappa, D2D3 vs. all else) for primary examiners combined were 0.58, 0.88, 0.67, and 0.71 for the baseline and 12-, 24-, and 33-month examinations, respectively (Bader et al., 2013).

Questionnaire Data

Participants completed a series of baseline and annual questionnaires that included information on demographics (including, age, gender, and race), medical history, and dental and oral health. Relevant questionnaire items considered for this secondary analysis included participants’ age, dental visit history, brushing/flossing frequency, and over-the-counter fluoride exposure (use of fluoridated toothpaste and fluoridated mouthwash after brushing). Complete questionnaire items are available at http://www.xactstudy.org.

Statistical Analyses

The primary outcome variable for the main X-ACT trial was the annualized D23FS (cavitated caries lesions) caries increment for combined root and coronal surfaces, computed as the weighted sum of changes (transitions) in tooth-surface status (Bader et al., 2010). Reversals were considered invalid transitions and scored 0. Null transitions (e.g., F to F), transitions from D2 to treated status (F or C), or to or from an unscorable status (e.g., missing surfaces) were also scored 0. In the secondary analysis reported here, we conducted separate analyses for root and coronal surfaces and, among the latter, for smooth (buccal and lingual), occlusal, and proximal surfaces.

Consistent with the trial’s primary outcome analysis, we used negative binomial (NB) regression to model the coronal increment scores. However, given the large number of zero increments for root surfaces, we used zero-inflated negative binomial (ZINB) regression to model the root increment scores (Preisser et al., 2012). Treatment was included in the log rate part of the ZINB model, but not in the logistic part (because it was believed that treatment would not affect zero-inflation). As a result, both the NB and ZINB models give rise to incidence rate ratios (IRR), representing overall effects for comparing the effect of xylitol vs. placebo lozenges on annualized mean caries increments. For both the NB and ZINB models, we included dental visit history, over-the-counter (OTC) fluoride exposure from toothpaste, mouthwash, or both, brushing/flossing habits, clinical site, and age as covariates and duration of follow-up as a model offset. For the coronal surfaces, we also assessed treatment by surface type interaction in a multivariate model, to test whether the effect of treatment varied across the different types of coronal surfaces. These analyses adjusted the standard errors to account for the intraclass correlation of the D2FS indices within participants using the clustered empirical sandwich estimator.

Finally, we also examined whether any ‘treatment by surface type’ effects differed by clinical site by examining whether the ‘clinical site by treatment’ (for root and coronal surface analyses) or the ‘clinical site by treatment by surface type’ (proximal, occlusal, and smooth coronal surface analysis) interactions were significant.

We used a two-tailed alpha of 0.05 to define statistical significance and conducted analyses using a combination of both SAS 9.2 (Cary, NC, USA) and Stata 11.2 (College Station, TX, USA).

Results

Among the 620 participants included in this secondary analysis, 308 were randomized to the xylitol arm and 312 to the placebo arm. Mean duration of follow-up was 2.61 yrs, and loss to follow-up was balanced between study arms. Mean age was 47.3 yrs (range, 21-80 yrs), and 65% were women (Table 1). The majority brushed at least twice/day and were exposed to fluoride through office visits or toothpaste, or both (communities in all 3 clinical sites have fluoridated municipal water). Very few reported having dry mouth. We observed similar participant characteristics across the clinical sites.

Table 1.

Baseline Characteristics of X-ACT Trial Participants with at Least One Follow-up Visit and Complete Data on All Covariates

All Clinical Sites Xylitol n = 308 Placebo n = 312 Total n = 620
Mean age in yrs (SD) 46.4 (13.5) 48.1 (13.7) 47.3 (13.6)
Race/Ethnicity
 Non-Hispanic white 44.5% 50.6% 47.6%
 Non-Hispanic black 28.9% 25.0% 26.9%
 Hispanic 23.4% 21.2% 22.3%
 Other 2.9% 3.2% 3.1%
Female 62.3% 66.7% 64.5%
Brushes 2+ times/day1 63.0% 69.9% 66.5%
Flosses 1+ times/day2 47.7% 47.4% 47.6%
Dental visit in past year3 31.8% 31.7% 31.8%
Self-reported dry mouth4 5.2% 8.0% 6.6%
Extent of fluoride exposure5
 Toothpaste or mouthwash fluoride 52.6% 61.5 % 57.1%
Both toothpaste and mouthwash fluoride 38.6% 31.1% 34.8%
1

Percentage of participants who self-reported brushing at least twice per day.

2

Percentage of participants who self-reported flossing at least once per day.

3

Percentage of participants who self-reported having had a routine dental visit for a dental examination or a dental cleaning in the year before the baseline study visit.

4

Percentage of participants who self-reported dry mouth when eating or constantly.

5

Percentages of participants who self-reported regularly using over-the-counter fluoridated toothpaste or mouthwash, or both, after brushing.

Xylitol’s effects on root and coronal caries increments, as well as for each coronal surface type, are presented in Table 2. Participants in the xylitol arm developed 40% fewer root caries lesions than those in the placebo arm (0.23 vs. 0.38 D2FS/yr; IRR = 0.60; 95% CI for IRR = [0.44, 0.81], p < .001). The magnitude of risk reduction was not significantly different across clinical sites. Coronal caries incidence rates did not differ significantly between participants in the xylitol and placebo arms (2.51 vs. 2.70 D2FS/yr; IRR = 0.93; 95% CI [0.83, 1.05], p = .242). Finally, the ‘treatment by surface type’ interaction in the unified coronal surfaces model was not significant (χ2 = 3.96, p = .138). We also compared the treatment effects across clinical sites and found no clinical site-specific effects.

Table 2.

Mean Annual D2FS Increments for Root and Coronal Surfaces1

Xylitol n = 308 Placebo n = 312 IRR2 95% CI3 p
Type of surface
 Root 0.234 0.38 0.60 [0.44, 0.81] < .001
 Coronal 2.51 2.70 0.93 [0.83, 1.05] .242
Type of coronal surface
 Smooth 1.06 1.19 0.89 [0.77, 1.02] .100
 Occlusal 0.38 0.35 1.09 [0.89, 1.34] .408
 Proximal 0.94 1.05 0.90 [0.77, 1.04] .159
1

Zero-inflated negative binomial regression was used for modeling root caries increment; the logistic part of the model did not include treatment, or brushing/flossing habits, the latter omitted due to convergence issues.

2

Incidence Rate Ratio.

3

Confidence Interval.

4

Model-based annualized means adjusted for clinical site, age, age-squared, dental visit history, over-the-counter fluoride use, oral hygiene practices, and severity of baseline caries (D2FS).

Discussion

Xylitol is a naturally occurring non-fermentable polyol used as a sugar substitute and is therefore considered a non-cariogenic sweetener (Maguire and Rugg-Gunn, 2003). Xylitol promotes remineralization by increasing salivary flow and inhibits bacterial growth and metabolism in the plaque biofilm (Ly et al., 2006; Milgrom et al., 2006; Söderling, 2009). Despite these favorable anti-cariogenic properties, the evidence for the clinical effectiveness of xylitol as a caries-preventive agent is controversial (Mäkinen, 1998; Scheie and Fejerskov, 1998). In addition, one recently published systematic review reported that the current evidence of the effect of xylitol for caries prevention contains high risk of bias and may be limited by confounder effects, suggesting that high-quality randomized trials are needed to evaluate xylitol’s effectiveness (Mickenautsch and Yengopal, 2012). Another recently published systematic review suggests that xylitol could have tooth-surface-specific caries-preventive effects (Antonio et al., 2011) but did not examine coronal vs. root surfaces. Furthermore, most evidence of xylitol for caries prevention is derived from studies on children and adolescents with no root surfaces at risk.

X-ACT was designed and conducted as a highly controlled randomized clinical trial to test the effectiveness of xylitol in preventing caries in adults. The placebo lozenge used in the trial was sweetened with sucralose, which lacks any plausible biologic cariostatic or cariogenic properties (Mandel and Grotz, 2002). Bader et al. (2013) found that daily consumption of 3 to 5 grams of xylitol in lozenges reduced the overall (coronal and root) caries increment by 11%, which was not statistically significant when compared with placebo use. However, when tooth surfaces were analyzed separately as in the current analysis, xylitol lozenges had a statistically significant caries-preventive effect on root surfaces, though not on coronal surfaces.

These results have important implications for root caries prevention and management and are consistent with previous reports of xylitol preventive effects on root surfaces (Mäkinen et al., 1995, 1996; Deshpande and Jadad, 2008). Although coronal caries is more prevalent than root caries, root caries is an increasingly important clinical problem in dentistry, with an annual incidence of 27% among older adults (Griffin et al., 2004; Ritter et al., 2010). Nonetheless, little research emphasis is given to preventing caries in adults and, specifically, to preventing root caries. A recent randomized clinical trial on root caries prevention in elders showed that oral hygiene instruction alone is less effective in preventing root caries than when preventive agents such as chlorhexidine varnish, sodium fluoride varnish, and silver diamine fluoride solution were used (Tan et al., 2010). While fluoride agents have been shown to be moderately effective in the prevention of root caries (Jensen and Kohout, 1988; Ekstrand et al., 2008), there is continuing interest in the study of alternative low-risk and low-cost anticaries agents (ten Cate, 2012; Walls and Meurman, 2012).

The results of this secondary analysis indicate that xylitol appears to be effective for root surface caries, but less so for coronal surface caries. There are several plausible explanations for this root-surface-specific effect. First, it is possible that there might be differences in composition/virulence between root and coronal biofilms (Sansone et al., 1993; Aamdal-Scheie et al., 1996; Huang et al., 2011), hence modifying the susceptibility of these substrates to xylitol effects and caries development. Supporting this hypothesis, it has been shown that some strains of oral bacteria are more sensitive to xylitol’s inhibitory effect than others (Söderling, 2009). Second, anatomic factors render root surfaces more prone to biofilm stagnation and plaque build-up, and xylitol may have a more pronounced effect in areas with stagnant biofilm such as root surfaces. This hypothesis is supported to some extent by the results of this analysis on the various coronal surfaces, i.e., xylitol appears to be more effective (although non-significantly) on smooth than on occlusal coronal surfaces. Third, it is known that the critical pH for dentin demineralization is higher than that for enamel demineralization (Featherstone, 2004). Because root surface caries is mostly a dentin caries phenomenon (as opposed to coronal enamel caries), it is plausible that xylitol exerts a higher caries-preventive effect at the pH range of dentin demineralization than that of enamel. However, it should be noted that the critical pH is not a constant, since the levels of calcium and phosphate in the biofilm fluid vary among individuals (Dawes, 2003).

Although we observed a significant preventive effect on root surfaces, these results are limited by the relatively small number of participants with root caries, given that approximately 70% of the root surfaces either were not at risk or had no disease. However, the observed root caries incidence is consistent with previously reported data (Griffin et al., 2004), considering that this was a high-risk population. The overall root caries (D2FS) 33-month incidence in the sample was 29.52% (24.03% in the xylitol arm, 34.94% in the placebo arm). As noted above, the mean age for participants in this study was 47 yrs. An older population would likely yield more representative results relative to root caries prevention. Another consideration is that, as reported above, all participants lived in communities with fluoridated water, and many used home care fluoride products (Table 1). Therefore, xylitol was an add-on intervention, and any interpretation of the observed results should take that into account. Finally, while the xylitol dosage used in X-CT was considered adequate when the trial was designed, more recent information suggests that the 5 gm/day dose may fall below a therapeutic threshold (Milgrom et al., 2009).

While the root-caries-preventive effect observed in this study was statistically significant (40% less root surface caries/yr), the magnitude of the risk reduction effect (0.15 surface/yr) was clinically modest. In light of the fact that this was a secondary analysis of the data, and the study’s primary outcome analysis was not statistically significant (Bader et al., 2013), these results should be viewed with caution. Nonetheless, we believe that these results, combined with those of previous studies, support the clinical recommendation that patients use xylitol lozenges – given their low cost, low risk, and ease of use – to help prevent root caries.

Acknowledgments

The authors thank the X-Act Data Safety and Monitoring Board and the X-Act participants who made this study possible.

The X-ACT collaborative research group is comprised of the following people: (from the University of North Carolina – Chapel Hill) Daniel A. Shugars, DDS, PhD, MPH, Jan C. Holland, RDH, MS, André V. Ritter, DDS, MS, MBA, Debbie S. Robinson, CDA, MS, and J. D. Bader, DDS, MPH; (from the University of Alabama – Birmingham) Gregg H. Gilbert, DDS, MBA, Sonia K. Makhija, DDS, MPH, and Mona Z. Anabtawi, DDS, MS; (from the University of Texas Health Sciences Center –San Antonio) Bennett T. Amaechi, BDS, MS, PhD, Anna Theresa Vega, RDA, Bithiah Radcliffe, John P. Brown, BDS, MS, PhD, and Belinda Vitolas, RDA; (from the Coordinating Center at the Kaiser Permanente Center for Health Research, OR) William M. Vollmer, PhD, Reesa L. Laws, BS, Michael C. Leo, PhD, Kimberly A. Funkhouser, BS, Donna J. Eubanks, BSCS, Kelly Kirk, C. Chen, PhD, Deborah Reck, Jeanette Bardsley, BA, Arthur R. Dixon, MSTM, and Elizabeth J. Esterberg, MS; and (from the NIDCR Project Office) Jane C. Atkinson, DDS

Footnotes

This work was supported by the following National Institute of Dental and Craniofacial Research grants: U01DE018038, U01DE018047, U01DE018048, U01DE018049, and U01DE018050. These are, respectively, the “Xylitol Adult Caries Trial (X-ACT) Study Chair,” “Xylitol Adult Caries Trial (X-ACT) Data Coordinating Center,” “Xylitol Adult Caries Trial (X-ACT) UNC Clinical Center,” “Xylitol Adult Caries Trial (X-ACT) UAB Clinical Center,” and the “Xylitol Adult Caries Trial (X-ACT) UTHSC San Antonio Clinical Center.”

The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.

References

  1. Aamdal-Scheie A, Luan WM, Dahlén G, Fejerskov O. (1996). Plaque pH and microflora of dental plaque on sound and carious root surfaces. J Dent Res 75:1901-1908. [DOI] [PubMed] [Google Scholar]
  2. Antonio AG, Pierro VS, Maia LC. (2011). Caries preventive effects of xylitol-based candies and lozenges: a systematic review. J Public Health Dent 71:117-124. [DOI] [PubMed] [Google Scholar]
  3. Bader JD, Shugars DA, Vollmer WM, Gullion CM, Gilbert GH, Amaechi BT, et al. (2010). Design of the xylitol for adult caries trial (X-ACT). BMC Oral Health 10:22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bader JD, Vollmer WM, Shugars DA, Gilbert GH, Amaechi BT, Brown JP, et al. (2013). Principal results from the Xylitol for Adult Caries Trial (X-ACT). J Am Dent Assoc 144:21-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Banting DW, Amaechi BT, Bader JD, Blanchard P, Gilbert GH, Gullion CM, et al. (2011). Examiner training and reliability in two randomized clinical trials of adult dental caries. J Public Health Dent 71:335-344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dawes C. (2003). What is the critical pH and why does a tooth dissolve in acid? J Can Dent Assoc 69:722-724. [PubMed] [Google Scholar]
  7. Deshpande A, Jadad AR. (2008). The impact of polyol-containing chewing gums on dental caries: a systematic review of original randomized controlled trials and observational studies. J Am Dent Assoc 139:1602-1614. [DOI] [PubMed] [Google Scholar]
  8. Ekstrand K, Martignon S, Holm-Pedersen P. (2008). Development and evaluation of two root caries controlling programmes for home-based frail people older than 75 years. Gerodontology 25:67-75. [DOI] [PubMed] [Google Scholar]
  9. Featherstone JD. (2004). The continuum of dental caries—evidence for a dynamic disease process. J Dent Res 83(Spec No C):C39-C42. [DOI] [PubMed] [Google Scholar]
  10. Featherstone JD. (2008). Dental caries: a dynamic disease process. Aust Dent J 53:286-291. [DOI] [PubMed] [Google Scholar]
  11. Fejerskov O, Kidd EAM. (2008). Dental caries: the disease and its clinical management. Oxford, UK: Wiley-Blackwell. [Google Scholar]
  12. Griffin SO, Griffin PM, Swann JL, Zlobin N. (2004). Estimating rates of new root caries in older adults. J Dent Res 83:634-638. [DOI] [PubMed] [Google Scholar]
  13. Huang R, Li M, Gregory RL. (2011). Bacterial interactions in dental biofilm. Virulence 2:435-444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ismail AI, Sohn W, Tellez M, Amaya A, Sen A, Hasson H, et al. (2007). The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries. Community Dent Oral Epidemiol 35:170-178. [DOI] [PubMed] [Google Scholar]
  15. Jensen ME, Kohout F. (1988). The effect of a fluoridated dentifrice on root and coronal caries in an older adult population. J Am Dent Assoc 117:829-832. [DOI] [PubMed] [Google Scholar]
  16. Khoo G, Zhan L, Hoover C, Featherstone JD. (2005). Cariogenic virulence characteristics of mutans streptococci isolated from caries-active and caries-free adults. J Calif Dent Assoc 33:973-980. [PubMed] [Google Scholar]
  17. Ly KA, Milgrom P, Roberts MC, Yamaguchi DK, Rothen M, Mueller G. (2006). Linear response of mutans streptococci to increasing frequency of xylitol chewing gum use: a randomized controlled trial [ISRCTN43479664]. BMC Oral Health 6:6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maguire A, Rugg-Gunn AJ. (2003). Xylitol and caries prevention—is it a magic bullet? Br Dent J 194:429-436. [DOI] [PubMed] [Google Scholar]
  19. Mäkinen KK. (1998). Xylitol-based caries prevention: is there enough evidence for the existence of a specific xylitol effect? Oral Dis 4:226-230. [DOI] [PubMed] [Google Scholar]
  20. Mäkinen KK, Bennett CA, Hujoel PP, Isokangas PJ, Isotupa KP, Pape HR, Jr, et al. (1995). Xylitol chewing gums and caries rates: a 40-month cohort study. J Dent Res 74:1904-1913. [DOI] [PubMed] [Google Scholar]
  21. Mäkinen KK, Pemberton D, Mäkinen PL, Chen CY, Cole J, Hujoel PP, et al. (1996). Polyol-combinant saliva stimulants and oral health in Veterans Affairs patients—an exploratory study. Spec Care Dentist 16:104-115. [DOI] [PubMed] [Google Scholar]
  22. Mandel ID, Grotz VL. (2002). Dental considerations in sucralose use. J Clin Dent 13:116-118. [PubMed] [Google Scholar]
  23. McDonald SP, Sheiham A. (1992). The distribution of caries on different tooth surfaces at varying levels of caries—a compilation of data from 18 previous studies. Community Dent Health 9:39-48. [PubMed] [Google Scholar]
  24. McIntyre JM, Featherstone JD, Fu J. (2000). Studies of dental root surface caries. 2: The role of cementum in root surface caries. Aust Dent J 45:97-102. [DOI] [PubMed] [Google Scholar]
  25. Mickenautsch S, Yengopal V. (2012). Anticariogenic effect of xylitol versus fluoride – a quantitative systematic review of clinical trials. Int Dent J 62:6-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Milgrom P, Ly KA, Roberts MC, Rothen M, Mueller G, Yamaguchi DK. (2006). Mutans streptococci dose response to xylitol chewing gum. J Dent Res 85:177-181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Milgrom P, Ly KA, Rothen M. (2009). Xylitol and its vehicles for public health needs. Adv Dent Res 21:44-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Preisser JS, Stamm JW, Long DL, Kincade ME. (2012). Review and recommendations for zero-inflated count regression modeling of dental caries indices in epidemiological studies. Caries Res 46:413-423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ritter AV, Shugars DA, Bader JD. (2010). Root caries risk indicators: a systematic review of risk models. Community Dent Oral Epidemiol 38:383-397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sansone C, Van Houte J, Joshipura K, Kent R, Margolis HC. (1993). The association of mutans streptococci and non-mutans streptococci capable of acidogenesis at a low pH with dental caries on enamel and root surfaces. J Dent Res 72:508-516. [DOI] [PubMed] [Google Scholar]
  31. Scheie AA, Fejerskov OB. (1998). Xylitol in caries prevention: what is the evidence for clinical efficacy? Oral Dis 4:268-278. [DOI] [PubMed] [Google Scholar]
  32. Seneviratne CJ, Zhang CF, Samaranayake LP. (2011). Dental plaque biofilm in oral health and disease. Chin J Dent Res 14:87-94. [PubMed] [Google Scholar]
  33. Söderling EM. (2009). Xylitol, mutans streptococci, and dental plaque. Adv Dent Res 21:74-78. [DOI] [PubMed] [Google Scholar]
  34. Tan HP, Lo EC, Dyson JE, Luo Y, Corbet EF. (2010). A randomized trial on root caries prevention in elders. J Dent Res 89:1086-1090. [DOI] [PubMed] [Google Scholar]
  35. ten Cate JM. (2012). Novel anticaries and remineralizing agents: prospects for the future. J Dent Res 91:813-815. [DOI] [PubMed] [Google Scholar]
  36. Walls AW, Meurman JH. (2012). Approaches to caries prevention and therapy in the elderly. Adv Dent Res 24:36-40. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Dental Research are provided here courtesy of International and American Associations for Dental Research

RESOURCES